Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Research Abstract |
My goal is to develop a novel therapeutic method for severe skin inflammatory diseases including atopic dermatitis(AD) targeting PKCη. Inhibition of PKCη activity by using the dominant negative type of PKCη improved the symptom such as erosiom and fissure on the back skin of AD model mice. Moreover, novel siRNA sequences for PKCη, which significantly repress the PKCη gene expression, were found.Furthermore, Stimulus by wound and reactive oxygen species existed as an upstream signal of PKCη, suggesting that these signals enhance AD symptom via the increase of PKCη activity.
|